等待开盘 04-02 09:30:00 美东时间
+0.220
+0.69%
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $40 to $42.
03-04 22:03
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
PACS Group shares are trading lower after the company reported mixed Q4 financi...
02-28 00:22
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and
01-21 06:47
The latest announcement is out from PACS Group Inc ( ($PACS) ). On December 19,...
2025-12-24 05:46
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.
2025-12-17 21:48
社交电商平台WeShop上市一周涨超275%;精密科学周涨超50%,获雅培230亿美元收购;SEMrush周涨近67%,获Adobe收购>>
2025-11-22 10:30